The seroprevalence of SARS-CoV-2-specific antibodies in children, Australia, November 2020 - March 2021.

Koirala A, Gidding HF, Vette K, Macartney K, PAEDS Serosurvey Group

Open source

DOI
10.5694/mja2.51542
Published
2022 Jul 4
Container
The Medical journal of Australia
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5694/mja2.51542,
  title = {The seroprevalence of SARS-CoV-2-specific antibodies in children, Australia, November 2020 - March 2021.},
  author = {Koirala A and Gidding HF and Vette K and Macartney K and PAEDS Serosurvey Group},
  year = {2022},
  journal = {The Medical journal of Australia},
  doi = {10.5694/mja2.51542},
  url = {https://doi.org/10.5694/mja2.51542}
}

RIS

TY  - JOUR
TI  - The seroprevalence of SARS-CoV-2-specific antibodies in children, Australia, November 2020 - March 2021.
AU  - Koirala A
AU  - Gidding HF
AU  - Vette K
AU  - Macartney K
AU  - PAEDS Serosurvey Group
PY  - 2022
JO  - The Medical journal of Australia
DO  - 10.5694/mja2.51542
UR  - https://doi.org/10.5694/mja2.51542
ER  - 

APA

A, K., HF, G., K, V., K, M., & Group, P. S. (2022). The seroprevalence of SARS-CoV-2-specific antibodies in children, Australia, November 2020 - March 2021.. The Medical journal of Australia. https://doi.org/10.5694/mja2.51542

Source records